ADVM — ADVERUM BIOTECHNOLOGIES INC

Ownership history in XTX Topco Ltd · 8 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ADVERUM BIOTECHNOLOGIES INC (ADVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.03% (2022 Q3)

Avg. % of fund

0.01%

First filed

2021 Q4

Last filed

2025 Q3

Quarters held

8

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	REDUCED	12,655	-17,100	-57.5%	0.00%	$57K	—
2025 Q2	REDUCED	29,755	-21,345	-41.8%	0.00%	$64K	—
2023 Q4	ADDED	51,100	+14,443	+39.4%	0.01%	$38K	—
2023 Q3	ADDED	36,657	+20,325	+124.4%	0.01%	$55K	—

% of Fund (quarterly)

Other funds also holding ADVM

As of 2025 Q3 — sorted by position size

BML Capital Management, LLC 3Y 12.68% Versant Venture Management, LLC 3Y 7Y 1.08% 5AM Venture Management, LLC 3Y 0.9% TCG Crossover Management, LLC 3Y 0.37% Frazier Life Sciences Management, L.P. 3Y 0.28% Pale Fire Capital SE 3Y 0.18% REGENERON PHARMACEUTICALS, INC. 0.12% Soleus Capital Management, L.P. 3Y 0.07% Quinn Opportunity Partners LLC 3Y 7Y 0.01% Waverly Advisors, LLC 3Y 7Y 0.01%

← Back to XTX Topco Ltd Holdings